摘要
虽然治疗和预防艾滋病毒取得了巨大进展,艾滋病疫情在全球范围内持续肆虐,2013年报道有210万例HIV感染者并且有160万患者因艾滋病死亡。因缺乏有效的疫苗,我们迫切需要新的治疗和预防方法。在预防艾滋病病毒方面,预防和疫苗研究一直是重点,这涉及到HIV-1包膜蛋白gp120与细胞表面受体的相互作用,研究者希望通过对这些相互作用更好的理解而找到预防甚至治疗HIV-1感染的新方法。目前的研究主要关注于HIV传播的早期阶段和HIV首次感染宿主细胞的关键期。本文讨论了HIV-1包膜蛋白和与传播相关的细胞表面受体之间的相互作用,这为开发预防HIV感染的新方法提供了机遇。
关键词: HIV-1,gp12,传播, 信号传导,整合素,α4β7。
图形摘要
Current Drug Targets
Title:HIV-1 gp120: A Target for Therapeutics and Vaccine Design
Volume: 17 Issue: 1
Author(s): Claudia Cicala, Fatima Nawaz, Katija Jelicic, James Arthos and Anthony S. Fauci
Affiliation:
关键词: HIV-1,gp12,传播, 信号传导,整合素,α4β7。
摘要: Although extraordinary progress has been made in the treatment and prevention of HIV infection, the AIDS pandemic continues to rage globally with 2.1 million infections and 1.6 million AIDS-related deaths reported in 2013. Until an effective vaccine is developed, new strategies for treatment and prevention are needed. Regarding the prevention of HIV infection, a major focus of prevention research in general and vaccine research in particular involves the interaction of the HIV-1 envelope protein gp120 with cell-surface receptors, with the hope that a greater understanding of these interactions will lead to the development of novel strategies aimed at preventing and even treating HIV-1 infection. Particular attention has been directed toward gaining a more precise understanding of the early events in transmission focusing on that critical window of time when HIV first establishes infection in the host. Here we describe some of the recent findings involving HIV-1 envelope interactions with cell surface receptors that are relevant to transmission and which may represent new opportunities to develop strategies to prevent HIV infection.
Export Options
About this article
Cite this article as:
Claudia Cicala, Fatima Nawaz, Katija Jelicic, James Arthos and Anthony S. Fauci , HIV-1 gp120: A Target for Therapeutics and Vaccine Design, Current Drug Targets 2016; 17 (1) . https://dx.doi.org/10.2174/1389450116666150825120735
DOI https://dx.doi.org/10.2174/1389450116666150825120735 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
System Level Meta-analysis of Microarray Datasets for Elucidation of Diabetes Mellitus Pathobiology
Current Genomics Chronic Vaccination with a Therapeutic EGF-Based Cancer Vaccine: A Review of Patients Receiving Long Lasting Treatment
Current Cancer Drug Targets Calcium Metabolism and Oxidative Stress in Bone Fractures: Role of Antioxidants
Current Drug Metabolism Mononuclear Cell Recruitment and Inflammation in Atherosclerosis
Vascular Disease Prevention (Discontinued) Applications of High Content Screening in Life Science Research
Combinatorial Chemistry & High Throughput Screening Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
Current Medicinal Chemistry Insulin Resistance in the HIV-Infected Population: The Potential Role of Mitochondrial Dysfunction
Current Drug Targets - Infectious Disorders Meet the Editorial Board:
Current Medicinal Chemistry Role of Prostaglandin (PG) and Peroxisome Proliferator-Activated Gamma (PPAR γ ) in Pulmonary Fibrosis
Current Respiratory Medicine Reviews Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches
Current Pharmaceutical Design Saponins in Tumor Therapy
Mini-Reviews in Medicinal Chemistry The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
Mini-Reviews in Medicinal Chemistry Immunotherapeutic Approaches in Pancreatic Adenocarcinoma: Current Status and Future Perspectives
Current Molecular Pharmacology The Novel VEGF<sub>121</sub>-VEGF<sub>165</sub> Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF<sub>165</sub>/Lon Signaling Through PI3K-AKT-mTOR Pathway
Current Cancer Drug Targets Editorial [Hot topic: Natural Antioxidants and their Derivatives:Biology and Clinical Application (Guest Editors: Thea Magrone, Yoshio Kumazawa & Emilio Jirillo)]
Current Topics in Medicinal Chemistry Commentary
CNS & Neurological Disorders - Drug Targets Prevention of Left Ventricular Remodelling after Acute Myocardial Infarction: An Update
Recent Patents on Cardiovascular Drug Discovery Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimers Disease
Current Neuropharmacology Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets